Model-guided determination of maximum tolerated dose in phase I clinical trials: evidence for increased precision.
Model-guided determination of maximum tolerated dose in phase I clinical trials: evidence for increased precision. J Natl Cancer Inst. 1993 Feb 03; 85(3):217-23.